Sign in
CompletedNo phase

Adjunctive Transcranial Stimulation to Reduce Impulsivity in Opiate Use Disorder

Key facts

Who runs it
Gopalkumar Rakesh
Where
Lexington, United StatesSee the site
Trial code
Status
Completed
People taking part
23 people enrolled
Started
15 Sept 2021
Ended
31 Jul 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Theta Burst Stimulation
  • Sham TMS
Record updated
22 October 2025

Who can take part

Age
18 years to 60 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (14)Hide the full registry criteria

Who can take part

  • Patients enrolled in the SMART Clinic at University of Kentucky
  • 18-60 years of age
  • Preferably right hand dominant
  • Currently self-report smoking 10 of more cigarettes per day or a score of > 5 on the Fagerstrom Test for Nicotine
  • Willing and able to abstain from all drug use
  • Exhaled breath on day of study CO < 10 ppm
  • Stabilized on maintenance buprenorphine if having comorbid opioid use disorder
  • Able to read and speak English
  • Able to provide informed consent to participate

Who cannot take part

  • Increased risk of seizure for any reason, including prior diagnosis of epilepsy, seizure disorder, increased intracranial pressure, or history of significant head trauma with loss of consciousness for ≥ 5 minutes which are all contraindications for TMS
  • History of traumatic brain injury or seizures which are contraindications for transcranial magnetic stimulation (TMS)
  • Presence of intracranial implants (e.g. aneurysms clips, shunts, stimulators, cochlear implants, or electrodes), cardiac pacemakers, or vagus nerve stimulation device which are all contraindications for magnetic resonance imaging
  • Neurological disorder including, but not limited to: space occupying brain lesion; any history of seizures, history of cerebrovascular accident; fainting, cerebral aneurysm, major neurocognitive disorder, Huntington chorea; multiple sclerosis which are all contraindications for TMS
  • Pregnant, nursing, or becoming pregnant during the study

Where in United States

  • 245 Fountain CourtLexington, United States

About the trial

What the trial wants to find out

The goal of this study is to examine the effect of four sessions of theta burst stimulation (TBS) versus sham TMS on attentional bias for smoking and opioid cues versus neutral stimuli in a population of patients with tobacco use disorder (TUD) with comorbid opioid use disorder (OUD) that is stable and on treatment with buprenorphine. The investigators will also examine the effect of TBS on craving for cigarettes as well as opioids. Participants will perform a stress induction procedure that mirrors an optimum combination of cues that trigger tonic craving in their environment while exposed to stress. All four sessions of TBS/sham TMS will be performed on the same day, with each session lasting for approximately 10 minutes and separated by 50 minute intervals.

The 2 groups in the trial

  • Active interventionExisting treatment, for comparison

    Four sessions of theta burst stimulation, amounting to 7200 pulses at 120% resting motor threshold. Targeting will be done using neuronavigation and processed resting state brain scan.

    Treatment: Theta Burst Stimulation

  • Sham TMSPlacebo, for comparison

    Four sessions of sham TMS. Targeting will be done using neuronavigation and processed resting state brain scan.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
22 October 2025